---
title: 'Prediction of pregnancy-related hypertensive disorders using metabolomics:
  a systematic review'
date: '2022-04-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/35470187/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20220427215006&v=2.17.6
source: metablomics[MeSH Terms]
description: 'CONCLUSIONS AND IMPLICATIONS: Metabolite signatures may contribute to
  further insights into the pathogenesis of pre-eclampsia and support screening tests.
  Nevertheless, it is mandatory to validate such methods in larger studies with a
  heterogeneous population to ascertain the potential for their use in clinical ...'
---
CONCLUSIONS AND IMPLICATIONS: Metabolite signatures may contribute to further insights into the pathogenesis of pre-eclampsia and support screening tests. Nevertheless, it is mandatory to validate such methods in larger studies with a heterogeneous population to ascertain the potential for their use in clinical ...